Abstract. Non-small cell lung cancer (NSCLC) exhibits radioresistance to conventional rays, due to its DNA damage repair systems. NSCLC may potentially be sensitized to radiation treatment by reducing those factors that continuously enhance the repair of damaged DNA. In the present study, normal lung fibroblast MRC-5 and lung cancer A549 cells were treated with NU7026 and CGK733, which are inhibitors of the DNA-dependent protein kinase catalytic subunit (PKcs) and ataxia telangiectasia mutated (ATM) and ataxia telangiectasia and Rad3-related (ATR), respectively, followed by exposure to X-rays and carbon ion irradiation. The cytotoxic activity, cell survival rate, DNA damage repair ability, cell cycle arrest and apoptosis rate of the treated cells were analyzed with MTT assay, colony formation assay, immunofluorescence and flow cytometry, respectively. The transcription and translation levels of the ATM, ATR and DNA-PKcs genes were detected by reverse transcription-quantitative polymerase chain reaction and western blotting, respectively. The results indicated that the radiosensitivity and DNA repair ability of A549 cells were reduced, and the percentages of apoptotic cells and those arrested at the G 2 /M phase of the cell cycle were significantly increased, following ionizing radiation with inhibitor-pretreatment. The expression levels of ATM, ATR, DNA-PKcs and phosphorylated histone H2AX, a biomarker for DNA double-strand breaks, were all upregulated at the transcriptional or translational level in A549 cells treated with carbon ion irradiation, compared with the control and X-rays-treated cells. In addition, the treatment with 5-50 µM NU7026 or CGK733 did not produce any obvious cytotoxicity in MRC-5 cells, and the effect of the DNA-PKcs-inhibitor on enhancing the radiosensitivity of A549 cells was stronger than that observed for the ATM and ATR-inhibitor. These findings demonstrated a minor role for ATM and ATR in radiation-induced cell death, since the upregulation of ATM and ATR did not rescue the A549 cells subjected to ionizing irradiation. Therefore, future studies on DNA-PKcs, ATM and ATR may lead to novel specific therapies that supplement general radiotherapy for the treatment of lung cancer.
Introduction
Lung cancer is responsible for the majority of mortalities from cancer worldwide, and is classified into small-cell lung cancer (SCLC) or non-small cell lung cancer (NSCLC) (1) (2) (3) . NSCLC is observed in ≤85% of cases of lung cancer, and its overall 5-year survival rate is 17.1% (1) (2) (3) . The radiotherapy treatment for NSCLC via conventional low-linear energy transfer (LET) X-rays and γ-rays (typically used to treat malignant cancer) presents disadvantages, including radiation-induced lung injury and radioresistance of lung cancer cells (4, 5) . By contrast, high-LET carbon ions possess several advantages on cancer treatment, including higher relative biological effectiveness, lower oxygen enhancement ratio and more uniform depth dose distribution than low-LET rays (6) . However, the detailed molecular mechanisms underlying heavy ion radiotherapy and its ability to reduce cellular radioresistance remain largely unclear.
Intrinsic radioresistance, cell proliferation and hypoxia are the 3 major radioresistance mechanisms in cancer cells (7, 8) . The problems associated with cell proliferation and hypoxia may be eliminated by accelerated radiotherapy with hypoxia modification. However, intrinsic radioresistance is a complex problem difficult to eliminate, due to the multiple signaling pathways involved (7, 8) . Previous studies have demonstrated that the phosphoinositide-3 kinase (PI3K)/protein kinase B (Akt) and PI3K/mammalian target of rapamycin (mTOR) signaling pathways may be frequently activated in certain cancer cells, regulating cellular processes such as proliferation, apoptosis and survival (8) (9) (10) . The PI3K family includes DNA-dependent protein kinase catalytic subunit (PKcs), ataxia telangiectasia mutated (ATM) and ataxia telangiectasia and Rad3-related (ATR), which participate in the DNA damage response pathway (11) . DNA-PKcs and ATM are involved in non-homologous end joining (NHEJ) and homologous recombination (HR) repair of DNA double-strand breaks (DSBs) (12) , while ATR is involved in the DNA damage response pathway to repair interrupted replication forks and extensive lesions in single-strand breaks (SSBs) (13) . Previous studies on the signaling differences between the DNA damage response to γ-rays and carbon ion irradiation observed an increased number of ATM and ATR foci following carbon ion irradiation, and suggested that the differences in DNA damage response to low-or high-LET may be due to distinct macromolecular complexes (14) . Similarly, Okayasu et al (15) noticed that radiation with iron ions at 2 Gy dose induced complex DNA damage, which was not repaired by the NHEJ pathway.
Inhibition of DNA-PKcs enhances radiosensitivity and increases the levels of ATM and ATR in NSCLC cells exposed to carbon ion irradiation
Since members of the PI3K family participate in maintaining the genomic integrity and chromosome stability, it has been hypothesized that these physiological processes may be associated with the radiosensitivity of NSCLC cells.
In the present study, the DNA-PKcs-inhibitor NU7026 and the ATM and ATR-inhibitor CGK733 were used to disrupt the NHEJ repair pathway, in order to investigate the potential alterations in the transcription and translation levels of the ATM, ATR, DNA-PKcs genes, and to determine the radiosensitivity of lung cancer A549 cells exposed to ionizing radiation. The results suggested that the upregulation of ATR/ATM potentially enhanced cellular radiosensitivity in A549 cells treated with the DNA-PKcs-inhibitor, since part of the DNA damage-sensing apparatus was inhibited following carbon ion irradiation. Therefore, high-LET carbon ions instead of low-LET X-rays may be used in the future to treat patients with lung cancer in the clinic. Further studies are required to investigate the potential use of DNA-PKcs, ATM and ATR in specific gene-radiotherapy approaches for the treatment of lung cancer.
Materials and methods
Cell culture and irradiation treatment. Normal lung fibroblast MRC-5 and lung cancer A549 cells were purchased from the American Type Culture Collection (Manassas, USA), and cultured in minimum essential medium and Dulbecco's modified eagle medium (Gibco Life Technologies, Carlsbad, USA) supplemented with 10% fetal bovine serum (HyClone, GE Healthcare Life Sciences, Logan, USA), respectively. The cells were incubated in humidified atmosphere at 37˚C in the presence of 5% CO 2 to maintain exponential cell growth.
A549 cells were irradiated at room temperature with 6 MV X-rays delivered by a PRIMUS linear accelerator (Siemens AG, Berlin, Germany) located in the Gansu Province Tumor Hospital (Lanzhou, China), at a dose rate of 200 cGy/min and source skin distance of 100 cm; or with 300 MeV carbon ion ( 12 C 6+ ) beams, provided at a dose rate of 1 Gy/min and LET of 49 KeV/µm, at the Heavy Ion Research Facility in Lanzhou (Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, China). The cells were exposed to 2 Gy, and radiation doses were determined based on previous pilot studies (11, 13, 14) . Non-irradiated A549 cells were handled in parallel with the irradiated cells.
MTT assay. MRC-5 and A549 cells were plated into 96-well dishes at a density of 5x10 4 cells/well. NU7026 and CGK733 (Abcam, Cambridge, UK) were added to each well at a final concentration of 5-50 µM, and incubated for 48 h. Thereafter, MTT (final concentration, 5 mg/ml) was added to each well. The medium was then removed, and the formazan crystals were dissolved by adding 150 µl dimethyl sulfoxide. The absorbance at 490 nm was subsequently measured in a microplate reader (Infinite M200; Tecan Group Ltd., Männedorf, Switzerland) (16, 17) .
Colony formation assay. A549 cells (2,000 cells) were seeded in a culture dish of 100 µm in diameter, and treated with 10 µM NU7026 or CGK733 for 30 min, prior to be exposed to 2 Gy X-ray and carbon ion irradiation. Following the addition of fresh medium, cell incubation continued under standard culture conditions (37˚C and 5% CO 2 ). The cells were washed with phosphate-buffered saline (PBS), fixed with ethanol and stained with Giemsa 10 days later. The number of colonies was calculated using a Multi Image™ Light Cabinet and the AlphaEase™ software (Alpha Innotech Corporation, San Leandro, CA, USA).
Cell cycle analysis. Cells were harvested and fixed in 70% ice-cold ethanol for >48 h at -20˚C. Subsequently, the cells were washed twice with PBS, resuspended in propidium iodide (PI) staining solution (5 µg/ml PI, 10 kU/ml RNaseA and 0.005% Triton X-100 in PBS) at a concentration of 1x10 6 cells/ml, and incubated in the dark at room temperature for 30 min. The cell cycle distribution was analyzed using a FACScan flow cytometer (BD Biosciences, Franklin Lakes, USA) and FlowJo version 7.6 software (FlowJo, LLC, Ashland, USA). γH2AX foci immunofluorescence. Cells were seeded in a 6-well plate at a density of 1x10 5 cells/well, and covered with a coverslip for 24 h to allow the cells to attach. Next, the cells were treated with NU7026 for 30 min, prior to being subjected to 2 Gy X-rays and carbon ion irradiation. At 0.5 h and 24 h post-irradiation, the cells were fixed with 4% paraformaldehyde for 15 min, and then treated with 0.1% Triton X-100 for 30 min and 5% bovine serum albumin (BSA) for 1 h. Next, the cells were incubated overnight at 4˚C with primary monoclonal antibody anti-γH2AX (1:500; Bioworld Technology, Inc., St. Louis, MO, USA) in the presence of 1% BSA. Cells were washed 3 times with PBST (0.05% Tween20) for 10 min, and incubated at room temperature for 1 h with IgG-fluorescein isothiocyanate in the presence of 1% BSA (1:5000; Cell Signaling Technology, Inc.). Following the addition of 1.5 µg/ml 4' ,6-diamidino-2-phenylindole (DAPI) to counterstain the nuclei. The coverslip containing the cells was then mounted with VECTASHIELD® Antifade Mounting Medium (Vector Laboratories, Inc., Burlingame, CA, USA). γH2AX foci were detected with a LSM 700 laser scanning confocal microscope (Zeiss, Oberkochen, Germany).
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR).
Total RNA was isolated from A549 cells with TRIzol (Invitrogen Life Technologies, Carlsbad, USA).
cDNA was synthesized with a PrimeScript™ RT reagent kit (Takara Biotechnology Co., Ltd., Dalian, China) in a total volume of 20 µl. Then, multiplex qPCR was performed in a total volume of 25 µl, using SYBR Green Master Mix (Takara Biotechnology Co., Ltd.), 50 ng DNA and 10 µM of each of the following primers from Takara Biotechnology Co., Ltd.: DNA-PKcs (forward, 5'-AGG GAA GAA GAG TCT CTG GTGG-3'; reverse, 5'-ATT AGG GGA TCT GTT GCC TGGC-3') (18); ATM (forward, 5'-ACT ATC CCA ATA CAC TGC TGG AGA-3'; reverse, 5'-TTT GAG CAA CTG ACT GGC AAAC-3'); ATR (forward, 5'-CCA AAG CGC CAC TGA ATGAA-3'; reverse, 5'-ACC TTG TAG TCG CTG CTC AAT GTC-3'); and GAPDH (forward, 5'-GAA GGT GAA GGT CGG AGTC-3'; reverse, 5'-GAA GAT GGT GAT GGG ATTTC-3').
The reaction was conducted on an FTC-3000 qPCR system (Shanghai Funglyn Biotech Co., Ltd., Shanghai, China), with the following cycling conditions: 30 sec at 95˚C, 40 cycles of 5 sec at 95˚C and 30 sec at 59˚C. Each PCR was repeated 3 times. The relative gene quantification approach (2 -ΔΔCt ) was used according to the method previously described (19) .
Western blotting. A549 cells were lysed in lysis buffer supplemented with 1 mM phenylmethylsulfonyl fluoride, and the protein concentration in the cell lysate was determined using a BCA assay kit (Pierce Biotechnology Inc., Rockford, USA). 20 µg of proteins from the whole-cell lysate was mixed with SDS buffer, separated on SDS-PAGE at 80 V for 2 h and transferred to polyvinylidene difluoride membranes (Bio-Rad Laboratories, Inc.) for 2 h. The membranes were then blocked for 1 h with PBS containing 5% BSA (Sigma-Aldrich), and incubated with the corresponding primary monoclonal rabbit antibody IgG anti-ATM, ATR, DNA-PKcs or β-actin (Cell Signaling Technology, Inc., Danvers, MA, USA) (1:1,000) at 4˚C overnight. Next, the membranes were washed with PBST for 30 min, and incubated with a goat anti-rabbit horseradish peroxidase-conjugated secondary antibody (1:5,000, Cell Signaling Technology, Inc.) for 1 h at room temperature. Following 3 washes with PBST for 10 min, a chemiluminescence kit (Santa Cruz Biotechnology, Inc., Dallas, TX, USA) was used to detect the reactive proteins. The data were represented as values relative to the protein levels of β-actin.
Statistical analysis. The data, presented as the mean ± standard deviation from ≥3 independent experiments, were evaluated for statistical significance with the Student's t-test, using Microsoft Excel software (Microsoft Corporation, Redmond, USA). P﹤0.05 was considered to indicate a statistically significant difference.
Results
The cytotoxicity of NU7026 and CGK733 was evaluated in A549 and MRC-5 cells. The effect of NU7026 or CGK733 on cell proliferation was determined by MTT assay following 48-h exposure of A549 and MRC-5 cells to the above inhibitors. At concentrations of NU7026 and CGK733 <10 µM, MRC-5 and A549 cells exhibited 2 and 10% inhibition rate, respectively, whereas at concentrations of NU7026 and CGK733 >20 µM, the inhibition rate of MRC-5 and A549 cells increased to >8 and 16%, respectively (Fig. 1) .
Compared with A549 cells treated with 5-50 µM NU7026 or CGK733, no obvious cytotoxicity was observed in MRC-5 cells, following treatment with NU7026 or CGK733 for 48 h (Fig. 1) . Consequently, 10 µM NU7026 and CGK733 were selected to examine the radiosensitivity of A549 cells in subsequent experiments.
NU7026-treatment and irradiation enhance cellular radiosensitivity. A549 cells were pretreated with NU7026 or CGK733 for 30 min, prior to be irradiated. To identify cellular alterations upon inhibitors-treatment and/or irradiation, the cells were analyzed under a microscope. A reduction in the number of cells and alterations in cell morphology were observed ( Fig. 2A) . Following 10 days, the survival fraction of cells exposed to carbon ion irradiation that had been pretreated with NU7026 reduced to 0.67%, compared with the control group (CK 98.75%, CK+U 90.82% and CK+G 92.63%) and the NU7026-pretreated cells exposed to 2 Gy X-ray irradiation (8.75%). The survival fraction of cells exposed to ionizing radiation following CGK733-treatment was higher than that of cells exposed to ionizing radiation following NU7026-treatment (Fig. 2B) . These results implied there was a significant increase in the radiosensitivity of A549 cells following NU7026-treatment and carbon ion irradiation.
NU7026-treatment and irradiation reduce DNA damage
repair. γH2AX is a marker of DSBs and also an important factor that recruits downstream proteins in response to DNA damage (20) . γH2AX foci were detected in A549 cells at 0.5 h and 24 h post-irradiation, regardless of prior NU7026 or CGK733-treatment (Fig. 3) . The X-ray+NU7026 and carbon+NU7026 groups exhibited a significant increase in γH2AX foci, compared with the groups treated with irradiation or CGK733 at 0.5 h (P﹤0.001). However, these γH2AX foci remained unaltered from 0.5 to 24 h post-irradiation, and did not dephosphorylate to repair DNA damage, indicating that the process of DNA repair had been completed (Fig. 3) . Therefore, the X-ray+NU7026 and carbon+NU7026 groups appeared to display a poorer ability to repair DNA damage from 0.5 to 24 h post-irradiation, compared with the other groups (Fig. 3B) . These results indicated that the NU7026-treatment led to a significant reduction in DNA damage repair, compared with the CGK733-treatment, in A459 cells exposed to ionizing radiation.
Exacerbated cell cycle G 2 /M phase arrest increases cell apoptosis.
Cell cycle arrest was examined by flow cytometry, and represented as a blue G 2 /M peak in a DNA histogram (Fig. 4A) . In contrast to 2 Gy X-rays irradiation with NU7026-treatment or 2 Gy carbon ion irradiation with CGK733-treatment, a clear increase in the percentage of cells arrested at the G 2 /M phase was observed in NU7026-pretreated A549 cells exposed to 2 Gy carbon ion 
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irradiation at 24 h post-irradiation (P﹤0.05 and P﹤0.001; Fig. 4B ). However, at 48 h post-irradiation, the number of A549 cells arrested at the G 2 /M phase significantly reduced following 2 Gy carbon ion irradiation, regardless of the pretreatment with NU7026 or CGK733. Therefore, as the time post-irradiation increased, the fraction of cells in the G 2 /M phase reduced. In contrast, the number of apoptotic cells rapidly increased (Fig. 4C) , and the percentage of cells treated with NU7026 or CGK733 at 48 h post-irradiation was higher than at 24 h post-irradiation. These results indicated that a pronounced G 2 /M arrest may contribute to cell apoptosis.
DNA-PKcs-inhibition enhances the transcription and translation of ATM and ATR.
When DNA-PKcs is inhibited, ATM and ATR regulate cell cycle arrest and apoptosis (21) . Therefore, RT-qPCR was performed at 24 h post-irradiation to quantify the relative expression levels of ATM and ATR in A549 cells that had been exposed to 2 Gy irradiation. Compared with the CK group (non-irradiated A549 cells), the gene levels of ATM and ATR were markedly upregulated in A459 cells following irradiation, and appeared to decline in A549 cells exposed to carbon ion irradiation plus NU7026-treatment versus NU7026-treatment alone (P﹤0.001; Fig. 5A ). In addition, the gene expression levels of ATM and ATR gradually increased in A549 cells, following X-rays and carbon ion irradiation alone, compared with the gradual reduction observed in NU7026-treated cells (Fig. 5A) . The ability of carbon ion irradiation to regulate the intracellular levels of ATM and ATR was opposite to the effects observed with X-rays irradiation. The results of western blotting for ATM and ATR were in agreement with those from RT-qPCR, and indicated high expression levels of ATR and ATM in A459 cells following carbon ion irradiation alone and carbon irradiation with NU7026-pretreatment, compared with control cells (Fig. 5B) .
To investigate the mechanisms that led to the observed reduced survival rate, increased percentage of cells in the G 2 /M phase, and increased apoptosis rate, following X-rays and carbon ion irradiation with or without NU7026-treatment in A459 cells, the expression levels of DNA-PKcs were examined in A549 cells treated with the ATM and ATR-inhibitor CGK733 and ionizing radiation. The gene and protein expression levels of DNA-PKcs were observed to be upregulated in A549 cells exposed to different LET rays and CGK733-pretreatment ( Fig. 5C and D) . In particular, the pretreatment with CGK733 and carbon ion irradiation significantly enhanced the levels of DNA-PKcs in A549 cells, compared with the other groups (P﹤0.001). These findings indicated that the inhibition of DNA-PKcs regulated cell apoptosis and cell cycle arrest following carbon ion irradiation through a mechanism upstream of ATM and ATR.
Discussion
Previous studies have demonstrated that high-LET radiation may produce high-clustered DNA damage, including DSBs, SSBs, oxidized bases, and apurinic and apyrmidinic sites (22) . Thus, the complexity of DNA damage produced by high-LET radiation is higher than that from low-LET radiation (22) . DNA-PKcs and ATM exhibit a critical sensory role in DSB repair through the NHEJ pathway in mammalian cells, while ATR is activated by SSBs to alleviate cellular genotoxic stress (21, (23) (24) (25) . DSBs can activate checkpoint signaling, and are usually repaired through the NHEJ and HR pathways (26) . HR occurs in the S and G 2 phases of the cell cycle, whereas NHEJ exists during the whole cell cycle (26) . Therefore, the additional inhibitory effect on NHEJ may retard the repair of carbon ion irradiation-induced DNA damage. In the present study, the inhibition of the NHEJ pathway led to the repair of carbon ion-induced DNA damage to become dependent on the slow HR DNA repair pathway. H2AX can be rapidly phosphorylated at Ser139, which is dependent on effector signals upstream of ATM, ATR and DNA-PKcs (13, 27, 28) . Previous studies have indicated that γH2AX foci may be a sensitive indicator of DSB formation and repair (29) . The results of the present study revealed that γH2AX foci of A549 cells were also increased by mechanisms upstream of ATM and ATR when the cells were treated with NU7026 or CGK733 and radiation for 0.5 h. The number of green foci observed in the irradiated A459 cells markedly reduced with time post-irradiation when the cells were subjected to X-rays and carbon ion irradiation alone, but not following X-rays and carbon ion irradiation with NU7026 or CGK733-pretreatment (Fig. 3) . These results indicated that the A459 cells that had been subjected to X-rays and carbon ion irradiation alone were experiencing DNA damage repair, as indicated by the marked reduction in the number of green foci, whereas the DNA damage repair was limited in those cells subjected to X-rays and carbon ion irradiation with NU7026-pretreatment, as indicated by their persistent green foci. The DNA damage repair induced by NU7026-treatment was limited, compared with the CGK733-treatment plus radiation, suggesting that the DNA damage repair ability of DNA-PKcs was stronger than that of ATM and ATR. In addition, a larger number of γH2AX foci were induced by high-LET particles, compared with low-LET X-rays. However, the downstream repair factors recruited by the formation of γH2AX foci did not function, leading to the continuous localization of γH2AX at unrepaired damage sites. These data also suggested that numerous damaged cells arrested in the G 2 /M phase were not capable of being repaired via the slow HR repair pathway alone. Previous studies have demonstrated that the formation of γH2AX foci depends on the presence of ATM, ATR and DNA-PKcs, following exposure to ionizing radiation (30, 31) . Furthermore, γH2AX triggered the G 2 /M checkpoint arrest by mediating the concentration of p53 binding protein 1 at the DSBs induced by ionizing radiation. Otherwise, the sole presence of these DSBs would be insufficient to prevent the damaged cells from entering mitosis (32) .
Previous studies have demonstrated that the principal biological task of the cell cycle is to create time for DNA damage repair. If the repair is successful, the cell cycle continues operating. If the DNA damage is too serious to be repaired, cells will undergo apoptosis (33, 34) . In the present study, the number of A549 cells arrested at the G 2 /M phase increased at 24 h post-irradiation when the cells were pretreated with NU7026 or CGK733 (Fig. 4) . Previous studies have suggested that cells accumulated in the G 2 /M phase were potentially subjected to apoptosis and sensitive to ionizing radiation (35, 36) . In the present study, the number of cells arrested at the G 2 /M phase markedly reduced with time post-irradiation, while the number of apoptotic cells increased from 24 to 48 h post-irradiation. This increase in G 2 /M phase arrest and apoptosis was induced by high-LET particles, compared with low-LET X-rays radiation. Furthermore, the effects exhibited by the DNA-PKcs-inhibitor NU7026 were more pronounced than those displayed by the ATM and ATR-inhibitor CGK733. Therefore, the increase in G 2 /M arrest appeared to enhance the radiosensitivity of A459 cells to carbon ion irradiation via apoptosis-associated cell death.
Previous studies have demonstrated that effectors located upstream of ATM, ATR and DNA-PKcs were able to initiate the G 2 /M cell cycle arrest and DNA damage repair pathway through other kinases (21, 37, 38) . In the present study, upregulation of ATM, ATR and DNA-PKcs in A459 cells was also evident following carbon ion irradiation with NU7026 or CGK733-pretreatment, which indicated that ATR, ATM and DNA-PKcs were involved in DNA damage repair, possibly through regulation of cell cycle arrest and apoptosis, rather than through the slow HR pathway. The upregulated ATR/ATM rate in ionized A459 cells observed in the present study was consistent with the results of previous studies (13, 14) . In addition, the effect of the DNA-PKcs-inhibitor on enhancing the radiosensitivity of A549 cells was stronger than the effect of the ATM and ATR-inhibitor, since the potent repair ability of DNA-PKcs was inhibited following carbon ion irradiation.
In conclusion, in the present study, the treatment with NU7026 increased the cellular radiosensitivity of lung cancer A549 cells to high-LET carbon ion irradiation, which may be due to the inhibition of DNA damage repair and the additional activation of ATM and ATR. Therefore, the results of the present study highlight the potential use of ATM and ATR in clinical radiotherapy for the treatment of NSCLC, since the exposure of lung cancer cells to high-LET rays jointly with NU7026, improved their cellular sensitivity to radiotherapy, compared with irradiation alone. Furthermore, the findings of the present study indicate the use of NU7026 in animal experiments and as a novel agent in gene-radiotherapy, since the compound did not produce any obvious toxic effects on normal lung fibroblasts. Future in vitro and in vivo studies on the combination of DNA-PKcs, ATM and ATR-inhibitors (39) are required in order to assess the beneficial effects of these drugs on the treatment of NSCLC in the clinic.
